Is Kymera Therapeutics, Inc. (KYMR) a Buy, Sell, or Hold?
NASDAQ : KYMR
Kymera Therapeutics, Inc.
$114.12 USD
$2.04 (1.82%)
- Volume
- 411.01K
- Average Volume
- 794.36K
- Market Capitalization
- $9.39B
- P/E Ratio
- -31.88
- Dividend Yield
- 0.00%
- Price Target
- $129.00
- Year High
- $130.05
- Year Low
- $36.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.81
KYMR vs. The Competition
| Properties | KYMR | AAPG | ACAD | ACLX |
|---|---|---|---|---|
| Market Cap | $9.39B | $1.88B | $4.44B | $6.73B |
| Shares Outstanding | $82.26M | $92.96M | $171.24M | $58.51M |
| P/E Ratio | -31.88 | -9.87 | 11.62 | -28.27 |
| EPS | -3.23 | -13.29 | 2.2 | -4.07 |
| Day Low | 110.155 | 19.4 | 25.1804 | 115.03 |
| Day high | 114.24 | 20.23 | 26.08 | 115.07 |
| Year Low | 36.65 | 16.36 | 19.69 | 50.85 |
| Year High | 130.05 | 48.45 | 28.35 | 115.13 |
| Average Price 50 | 91.7363 | 18.98914 | 22.7308 | 112.6244 |
| Average Price 200 | 79.0074 | 26.0605 | 23.36815 | 84.1487 |
| Volume | 411.01K | 15213 | 1.27M | 13.19M |
| Average Volume | - | - | - | - |